Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Mucin 1 - Pipeline Review, H2 2018 -

Research and Markets
Posted on: 19 Oct 18

The "Mucin 1 - Pipeline Review, H2 2018" drug pipelines has been added to's offering.

This report outlays comprehensive information on the Mucin 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Mucin 1 targeted therapeutics development with respective active and dormant or discontinued projects.
  • The report provides a snapshot of the global therapeutic landscape for Mucin 1
  • The report reviews Mucin 1 targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in Mucin 1 targeted therapeutics and enlists all their major and minor projects
  • The report assesses Mucin 1 targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news and deals related to Mucin 1 targeted therapeutics

Companies Featured

  • Akshaya Bio Inc.
  • Bavarian Nordic A/S
  • Bioleaders Corp.
  • Boehringer Ingelheim GmbH
  • Etubics Corp.
  • GeoVax Labs Inc.
  • Merck KGaA
  • Minerva Biotechnologies Corp.
  • NantKwest Inc.
  • Peptron Inc.
  • Transgene SA
  • Vaxil Bio Therapeutics Ltd.

For more information about this drug pipelines report visit

View source version on

Business Wire

Last updated on: 19/10/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.